Akebia Therapeutics (AKBA)
(Real Time Quote from BATS)
$1.36 USD
+0.01 (0.74%)
Updated Sep 19, 2024 03:34 PM ET
2-Buy of 5 2
C Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.04 |
Last EPS Surprise | 33.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.19 |
Next Year | -0.17 |
EPS (TTM) | -0.21 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.66M | 55.14M | 177.06M | 150.07M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 45.82M | 55.75M | 177.51M | 170.83M |
Low Estimate | 45.50M | 54.52M | 176.60M | 129.31M |
Year ago Sales | 42.05M | 56.20M | 194.75M | 177.06M |
Year over Year Growth Est. | 8.59% | -1.90% | -9.08% | -15.24% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | -0.03 | -0.19 | -0.17 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.06 | -0.04 | -0.22 | -0.43 |
High Estimate | -0.03 | -0.01 | -0.16 | 0.09 |
Low Estimate | -0.06 | -0.04 | -0.22 | -0.43 |
Year ago EPS | -0.08 | 0.00 | -0.28 | -0.19 |
Year over Year Growth Est. | 37.50% | NA | 32.14% | 10.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | -0.03 | -0.19 | -0.17 |
7 Days Ago | -0.05 | -0.03 | -0.19 | -0.17 |
30 Days Ago | -0.05 | -0.03 | -0.19 | -0.17 |
60 Days Ago | -0.08 | -0.05 | -0.28 | -0.23 |
90 Days Ago | -0.08 | -0.05 | -0.28 | -0.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.03 | -0.19 | -0.17 |
Zacks Consensus Estimate | -0.05 | -0.03 | -0.19 | -0.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.04 | -0.09 | 0.00 | -0.08 | NA |
Estimate | -0.06 | -0.09 | -0.05 | -0.09 | NA |
Difference | 0.02 | 0.00 | 0.05 | 0.01 | 0.02 |
Surprise | 33.33% | 0.00% | 100.00% | 11.11% | 36.11% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more